Advertisement
Screener

The Cigna Group (CI) Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest

The Cigna Group Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest

The Cigna Group (CI) reported Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest of $1.11 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.

Financial Statements › Income Statement › Unrealized Gains

us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-07-30

  • The Cigna Group comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for the quarter ending 2026-06-30 was $1.11B, a 20.91% decline year-over-year.
  • The Cigna Group comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for the quarter ending 2026-03-31 was $1.07B, a 7.84% decline year-over-year.
  • The Cigna Group comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for the quarter ending 2025-12-31 was $1.27B, a 6.70% decline year-over-year.
  • The Cigna Group comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for the quarter ending 2025-09-30 was $1.99B, a 80.25% increase year-over-year.
  • The Cigna Group comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for fiscal 2025 was $5.82B, a 76.40% increase from fiscal 2024.
  • The Cigna Group comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for fiscal 2024 was $3.30B, a 36.10% decline from fiscal 2023.
  • The Cigna Group comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for fiscal 2023 was $5.17B.
  • The Cigna Group comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for fiscal 2019 was $5.88B, a 162.61% increase from fiscal 2018.
Period endComprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 monthComprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 monthComprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 monthComprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month
2026-06-30$1.11B
10-Q · filed 2026-07-30
$2.18B
10-Q · filed 2026-07-30
$3.45B
derived: sum of 3 quarters · filed 2026-07-30
$5.44B
derived: sum of 4 quarters · filed 2026-07-30
2026-03-31$1.07B
10-Q · filed 2026-04-30
$2.34B
derived: sum of 2 quarters · filed 2026-04-30
$4.33B
derived: sum of 3 quarters · filed 2026-04-30
$5.73B
derived: sum of 4 quarters · filed 2026-07-30
2025-12-31$1.27B
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$3.26B
derived: sum of 2 quarters · filed 2026-02-26
$4.66B
derived: sum of 3 quarters · filed 2026-07-30
$5.82B
10-K · filed 2026-02-26
2025-09-30$1.99B
10-Q · filed 2025-10-30
$3.40B
derived: sum of 2 quarters · filed 2026-07-30
$4.56B
10-Q · filed 2025-10-30
$5.91B
derived: sum of 4 quarters · filed 2026-07-30
2025-06-30$1.41B
10-Q · filed 2026-07-30
$2.57B
10-Q · filed 2026-07-30
$3.92B
derived: sum of 3 quarters · filed 2026-07-30
$5.03B
derived: sum of 4 quarters · filed 2026-07-30
2025-03-31$1.16B
10-Q · filed 2026-04-30
$2.52B
derived: sum of 2 quarters · filed 2026-04-30
$3.62B
derived: sum of 3 quarters · filed 2026-04-30
$5.13B
derived: sum of 4 quarters · filed 2026-04-30
2024-12-31$1.36B
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$2.46B
derived: sum of 2 quarters · filed 2026-02-26
$3.97B
derived: sum of 3 quarters · filed 2026-02-26
$3.30B
10-K · filed 2026-02-26
2024-09-30$1.10B
10-Q · filed 2025-10-30
$2.62B
derived: sum of 2 quarters · filed 2025-10-30
$1.94B
10-Q · filed 2025-10-30
2024-06-30$1.51B
10-Q · filed 2025-07-31
$839.00M
10-Q · filed 2025-07-31
2024-03-31-$672.00M
10-Q · filed 2025-05-02
2023-12-31$5.17B
10-K · filed 2026-02-26
2019-12-31$899.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
$2.36B
derived: sum of 2 quarters · filed 2020-02-27
$4.09B
derived: sum of 3 quarters · filed 2020-02-27
$5.88B
10-K · filed 2020-02-27
2019-09-30$1.46B
10-Q · filed 2019-10-31
$3.19B
derived: sum of 2 quarters · filed 2019-10-31
$4.99B
10-Q · filed 2019-10-31
$5.28B
derived: sum of 4 quarters · filed 2020-02-27
2019-06-30$1.73B
10-Q · filed 2019-08-01
$3.52B
10-Q · filed 2019-08-01
$3.82B
derived: sum of 3 quarters · filed 2020-02-27
$4.57B
derived: sum of 4 quarters · filed 2020-02-27
2019-03-31$1.80B
10-Q · filed 2019-05-02
$2.10B
derived: sum of 2 quarters · filed 2020-02-27
$2.85B
derived: sum of 3 quarters · filed 2020-02-27
$3.35B
derived: sum of 4 quarters · filed 2020-02-27
2018-12-31$297.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
$1.05B
derived: sum of 2 quarters · filed 2020-02-27
$1.55B
derived: sum of 3 quarters · filed 2020-02-27
$2.24B
10-K · filed 2020-02-27
2018-09-30$751.00M
10-Q · filed 2019-10-31
$1.25B
derived: sum of 2 quarters · filed 2019-10-31
$1.94B
10-Q · filed 2019-10-31
2018-06-30$504.00M
10-Q · filed 2019-08-01
$1.19B
10-Q · filed 2019-08-01
2018-03-31$689.00M
10-Q · filed 2019-05-02
2017-12-31$2.53B
10-K · filed 2020-02-27
2016-12-31$1.70B
10-K · filed 2019-02-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
Elevance Health, Inc. (ELV)United States$86.364B16.90
HUMANA INC (HUM)United States$45.651B18.44
CENTENE CORP (CNC)United States$30.588B-6.22
MOLINA HEALTHCARE, INC. (MOH)United States$10.091B-1,697.50
Alignment Healthcare, Inc. (ALHC)United States$1.593B121.28
TRUPANION, INC. (TRUP)United States$0.984B
UNITEDHEALTH GROUP INC (UNH)United States$336.652B26.62